Adaptimmune adaptimmune.com


Public list: Smart Money VCs (6328) Pharma Startups (4732) Cancer Therapeutics (1137)

Adaptimmune is focused on the use of T cell therapy with engineered T cell receptors to treat cancer and infectious disease. Established in July 2008 with a research base in Oxford, UK and a clinical base in Philadelphia, US, the company aims to utilise the body's own machinery – the T cell – to target and destroy cancerous or infected cells by using engineered, increased affinity T cell receptor (TCRs) as a means of strengthening natural patient T cell responses. Adaptimmune undertakes all ...Show all

Adaptimmune is focused on the use of T cell therapy with engineered T cell receptors to treat cancer and infectious disease. Established in July 2008 with a research base in Oxford, UK and a clinical base in Philadelphia, US, the company aims to util...Show all

Company (IPO / Went public)

Phone: +44 (0) 1235 430000

Fax:

91 Park Drive, Milton Park
Abingdon
Oxon, OX14 4RY
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Adaptimmune $298.4M May 6, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Adaptimmune Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 13 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
T cells with increased immunosuppression resistance Sep 22, 2017 May 22, 2018 Patent
Vectors for transgene expression Oct 24, 2014 Apr 03, 2018 Patent
High affinity ny-eso t cell receptors Oct 12, 2016 Nov 21, 2017 Patent
High affinity ny-eso t cell receptors Dec 14, 2015 Dec 06, 2016 Patent
T cell receptor display Apr 10, 2014 Sep 20, 2016 Patent
See all 17 patents